North America Brain Implants Market Forecast to 2030
North America Brain Implants Market Forecast to 2030 – Regional Analysis – by Treatment [Deep Brain Stimulation, Spinal Cord Stimulation, Vagus Nerve Stimulator, Invasive and Non-Invasive Brain-Computer Interface, Responsive Neurostimulation for Seizures, Auditory Brainstem Implant (Retrocochlear Hearing Impairment and Cochlear Hearing Impairment), and Ophthalmic Aid/Implant], Application [Chronic Pain, Parkinson’s Disease, Alzheimer’s Disease, Epilepsy, Essential Tremor, Depression, Dystonia, Amyotrophic Lateral Sclerosis (ALS), and Neurofibromatosis 2], and End User (Hospitals and Specialized Clinics/Neurological Centers)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Surging Prevalence of Neurological Disorders with Increasing Geriatric Population Fuels North America Brain Implants Market
With age, elderly people are likely to develop neurological disorders that impact their mobility. Alzheimer’s disease, epilepsy, Parkinson’s disease (PD), and dystonia are among the most common neurological disorders affecting the geriatric population. According to the 2020 population statistics by the US Census Bureau, the geriatric population reached 55.8 million, i.e., 16.8% of the national population; nearly 1 in 6 people in the country were aged 65 and above in 2020. Further, as per the data published by the Fraser Institute, the share of Canada’s population aged 65 or older increased from 14% in 2010 to 19% in 2022 and is expected to reach 22.5% by 2030. According to an article published by UpToDate Inc. in August 2021, the incidence rate of epilepsy rises with age and is highest among patients aged 75 and above.
Countries such as the US and Canada have high prevalence rates of movement disorders and psychiatric disorders associated with growing geriatric populations. According to the Parkinson’s Foundation, Parkinson’s symptoms are common at an average age of 60. For instance, ~90,000 Americans are diagnosed with PD yearly. The organization also states that the incidence of PD increases with age; nearly 1 million people in the US are living with PD, and the number is expected to reach 1.2 million by 2030. According to an article titled “Alzheimer’s disease: Can deep brain stimulation help alleviate symptoms” published in April 2023, ~32 million people worldwide have Alzheimer’s disease. As per the Alzheimer’s Disease Research Factsheet, published by BrightFocus Foundation in October 2022, ~500,000 new cases of Alzheimer’s disease were diagnosed in 2022 in the US. The incidence rate of Alzheimer’s increases with age. ~6.5 million Americans aged 65 and above are suffering from Alzheimer’s disease, and the number is expected to reach 12.7 million by 2050. According to the World Health Organization (WHO) stats released in February 2022, approximately 50 million people suffer from epilepsy, which is one of the most common neurological diseases worldwide.
The increasing incidence of neurological diseases, coupled with the growing geriatric population, drives the demand for brain implants to treat and manage the disease. The deep brain stimulation (DBS) technique is used to treat epilepsy cases due to the low therapeutic response exhibited by the patient’s body to medication during seizures and reduced success rates associated with surgeries. Researchers from the University of North Carolina at Chapel Hill claim to have generated new neurons in the brain, which can be stimulated using DBS. DBS for Alzheimer’s involves utilizing an implanted device similar to a heart pacemaker and two attached wires that deliver mild electrical pulses directly to the fornix area of the brain. Electrical stimulation can activate the memory circuitry in the brain to sharpen its function. Thus, neural implants such as DBS and vagus nerve stimulation are increasingly being used to treat patients with PD and other neurological conditions.
North America Brain Implants Market Overview
The North America brain implants market is segmented into the US, Canada, and Mexico. In 2022, the US held the largest market share in this region and is expected to continue its dominance during the forecast period. The increasing prevalence of neurological diseases such as Parkinson’s disease (PD), growing awareness about neurological disorders, positive research results, and growing investments in developing various stimulators are among the main factors driving the overall market growth for brain implants in the US. According to the Parkinson’s Foundation, 930,000 people in the US were suffering from PD in 2020, and the number is expected to increase to 1.2 million by 2030. Brain implants, such as deep brain stimulation (DBS), have proven to be potential treatment options for PD. DBS devices have been observed to be effective in controlling tremors associated with PD. As per the Oregon Health & Science University (OSHU) Brain Institute, in the US, ~90% of patients with essential tremors experienced moderate relief from symptoms after DBS.
According to a study titled “2022 Alzheimer’s disease facts and figures,” published in March 2022, ~6.5 million Americans aged 65 and above were found to have Alzheimer’s disease in 2022, and the number is projected to rise to 13.8 million by 2060. Moreover, major market players focus on introducing new versions of DBS devices. In March 2023, researchers at Michigan Technological University used neuromorphic computing to improve the efficacy and energy efficiency of DBS systems used to treat PD. Similarly, researchers from the University of North Carolina at Chapel Hill discovered that they were able to generate new neurons in the brain and stimulate them using DBS. This process helped restore cognitive and noncognitive functions in a mouse model that had Alzheimer’s disease.
Technological advancements and new product launches drive the growth of the US brain implants market. In January 2020, Abbott’s Infinity DBS System received US Food and Drug Administration (FDA) approval for treating PD. This system targets a specific area of the brain (the inner globus pallidus), which is associated with the symptoms of PD. In September 2020, Boston Scientific announced the European launch of the WaveWriter Alpha portfolio of SCS systems. In May 2023, Abbott received approval from the US FDA for spinal cord stimulator (SCS) devices to treat chronic back pain in people who are not recommended to receive back surgery. In September 2023, Neuralink received approval from an independent review board to initiate recruitment for the first human trial of brain implants for paralysis patients. The study will involve a robot to surgically place a brain-computer interface (BCI) implant in the area of the brain that controls bodily movements.
Therefore, increasing prevalence of neurological diseases, rising research and development activities, and technological advancements in brain implants are expected to bolster the brain implants market growth in the future.
North America Brain Implants Market Revenue and Forecast to 2030 (US$ Million)
North America Brain Implants Market Segmentation
The North America brain implants market is segmented into treatment, application, end user, and country.
Based on treatment, the North America brain implants market is classified into deep brain stimulation, spinal cord stimulation, vagus nerve stimulator, invasive and non-invasive brain-computer interface, responsive neurostimulation for seizures, auditory brainstem implant, and ophthalmic aid/implant. Further, the auditory brainstem implant segment is bifurcated into retrocochlear hearing impairment and cochlear hearing impairment. The spinal cord stimulation segment held the largest share in 2022.
In terms of application, the North America brain implants market is categorized into chronic pain, Parkinson’s disease, Alzheimer’s disease, epilepsy, essential tremor, depression, dystonia, amyotrophic lateral sclerosis (ALS), and neurofibromatosis 2. The chronic pain segment held the largest share in 2022.
Based on end user, the North America brain implants market is bifurcated into hospitals and specialized clinics/neurological centers. The hospitals segment held the largest share in 2022.
Based on country, the North America brain implants market is segmented the US, Canada, and Mexico. The US dominated the North America brain implants market in 2022.
Abbott Laboratories, Blackrock Microsystems Inc, Boston Scientific Corp, BrainGate, Fisher Wallace Laboratories Inc, Functional Neuromodulation Ltd, Medtronic Plc, Neuralink Corp, NeuroPace Inc, NeuroSky Inc, Neurospine LLC, ONWARD Medical NV, Paradromics Inc, Renishaw Plc, and Synchron Inc are some of the leading companies operating in the North America brain implants market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the North America brain implants market was valued at US$ 3,131.97 million in 2022 and is expected to reach US$ 7,768.72 million by 2030, registering a CAGR of 12.0% from 2022 to 2030. Technological advancements such as miniaturization, artificial intelligence, and modern brain-machine interfaces, and strategic initiatives by companies are among the critical factors attributed to the North America brain implants market expansion.
Advancements in technology have led to the development of smaller, more compact brain implants, making them more suitable for noninvasive or minimally invasive surgical procedures. Improved electrode designs, advanced programming algorithms, 3D printing, brain-computer interfaces (BCI), motor neuron prostheses, self-charging implants, memory chips, and miniaturization are a few of the modern trends in the brain implants market, which are likely to improve the effectiveness of treatments. These innovations provide patients with greater customization, adaptability, and other long-term benefits. In addition to the development of smaller and more flexible implants, advancements in wireless communication and power delivery systems can enhance the functionality and usability of brain implants. By reducing the invasiveness and improving the user experience, these advancements can expand the potential applications of brain implants and attract a broader patient population. Furthermore, these advancements benefit patients who require long-term implants, as smaller devices can lower the risk of complications and allow for easier placement and removal.
The integration of artificial intelligence (AI) and machine learning algorithms can further optimize the performance of brain implants by enabling personalized therapies and real-time adaptive stimulation. AI-powered neural implants have the potential to improve patients’ quality of life, particularly those suffering from Alzheimer’s disease. Recent research indicates that AI-powered brain-machine interfaces can effectively identify and track the progression of Alzheimer’s, leading to earlier diagnosis and intervention. Innovations in BCI technology have provided new ways for communication and control for individuals with severe disabilities. BCIs can enable individuals with locked-in syndrome or spinal cord injuries to interact with their surroundings using their thoughts. These implants can decode neural signals and translate them into commands for external devices, such as prosthetic limbs or computer interfaces.
Companies such as Medtronic, Neuropace, and St. Jude Medical are developing systems to actively monitor brain activity. Some monitoring systems are used in conjunction with other assistive devices, such as robotic aids, to help patients suffering from neurological disorders to regain lost motor function. Companies such as Emotiv and NeuroSky are focused on advancing BCIs for improved device control. In May 2023, Neuralink, a brain implant company, received US FDA approval to begin the first-in-human clinical study of its brain implants in human subjects. The company is working on developing implants that promise to incorporate human brains with computer interfaces via AI. Similarly, in February 2023, Precision Neuroscience began working on its plan to introduce its groundbreaking medical technology to benefit paralyzed patients or those with other forms of limited mobility. Precision’s brain implant device is a super thin film, about one-fifth of the width of a human strand of hair, that has a related consistency to that of a scotch tape. The company has plans to roll out the functionality of this device in stages.
On the contrary, high cost associated with brain implant devices and procedures hampers the growth North America brain implants market.
Based on treatment, the North America brain implants market is classified into deep brain stimulation, spinal cord stimulation, vagus nerve stimulator, invasive and non-invasive brain-computer interface, responsive neurostimulation for seizures, auditory brainstem implant, and ophthalmic aid/implant. The spinal cord stimulation segment held 37.7% share of the North America brain implants market in 2022, amassing US$ 1,180.44 million. It is projected to garner US$ 2,011.53 million by 2030 to expand at 6.9% CAGR during 2022-2030. Further, the auditory brainstem implant segment is bifurcated into retrocochlear hearing impairment and cochlear hearing impairment.
Based on application, the North America brain implants market is categorized into chronic pain, Parkinson’s disease, Alzheimer’s disease, epilepsy, essential tremor, depression, dystonia, amyotrophic lateral sclerosis (ALS), and neurofibromatosis 2. The chronic pain segment held 38.6% share of the North America brain implants market in 2022, amassing US$ 1,208.36 million. It is projected to garner US$ 2,878.69 million by 2030 to expand at 11.5% CAGR during 2022-2030.
Based on end user, the North America brain implants market is bifurcated into hospitals and specialized clinics/neurological centers. The hospitals segment held 71.6% share of the North America brain implants market in 2022, amassing US$ 2,243.31 million. It is projected to garner US$ 5,787.19 million by 2030 to expand at 12.6% CAGR during 2022-2030
Based on country, the North America brain implants market is categorized into the US, Canada, and Mexico. The US held 85.1% share of North America brain implants market in 2022, amassing US$ 2,665.10 million. It is projected to garner US$ 6,677.70 million by 2030 to expand at 12.2% CAGR during 2022-2030.
Key players operating in the North America brain implants market are Abbott Laboratories, Blackrock Microsystems Inc, Boston Scientific Corp, BrainGate, Fisher Wallace Laboratories Inc, Functional Neuromodulation Ltd, Medtronic Plc, Neuralink Corp, NeuroPace Inc, NeuroSky Inc, Neurospine LLC, ONWARD Medical NV, Paradromics Inc, Renishaw Plc, and Synchron Inc, among others.
In June 2023; Boston Scientific Corp received US Food and Drug Administration (FDA) approval for the Vercise Neural Navigator 5 Software, which when used as part of the Vercise Genus Deep Brain Stimulation (DBS) Systems. It provides clinicians with simple and actionable data for efficient programming in the treatment of people living with Parkinson’s disease or essential tremor.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in North America brain implants market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Brain Implants Market Landscape
4.1 Overview
4.2 North America PEST Analysis
5. North America Brain Implants Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Surging Prevalence of Neurological Disorders with Increasing Geriatric Population
5.1.2 Rising Number of Spinal Cord Injuries
5.2 Key Market Restraints
5.2.1 High Cost Associated with Brain Implant Devices and Procedures
5.3 Key Market Opportunities
5.3.1 Strategic Initiatives by Companies
5.4 Key Future Trends
5.4.1 Technological Advancements such as Miniaturization, Artificial Intelligence, and Modern Brain-Machine Interfaces
5.5 Impact Analysis:
6. Brain Implants Market – North America Market Analysis
6.1 Overview
6.2 North America Brain Implants Market Revenue (US$ Mn), 2022 – 2030
7. North America Brain Implants Market – Revenue and Forecast to 2030 – by Treatment
7.1 Overview
7.2 North America Brain Implants Market Revenue Share, by Treatment, 2022 & 2030 (%)
7.3 Deep Brain Stimulation
7.3.1 Overview
7.3.2 Deep Brain Stimulation: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Spinal Cord Stimulation
7.4.1 Overview
7.4.2 Spinal Cord Stimulation: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Vagus Nerve Stimulator
7.5.1 Overview
7.5.2 Vagus Nerve Stimulator: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Invasive and Non-Invasive Brain-Computer Interfaces
7.6.1 Overview
7.6.2 Invasive and Non-Invasive Brain-Computer Interfaces: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Responsive Neurostimulation for Seizures
7.7.1 Overview
7.7.2 Responsive Neurostimulation for Seizures: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Auditory Brainstem Implant
7.8.1 Overview
7.8.2 Auditory Brainstem Implant: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.8.2.1 Retrocochlear Hearing Impairment
7.8.2.1.1 Retrocochlear Hearing Impairment: Auditory Brainstem Implants Market- Revenue and Forecast to 2030 (US$ Million)
7.8.2.2 Cochlear Hearing Impairment
7.8.2.2.1 Cochlear Hearing Impairment: Auditory Brainstem Implants Market- Revenue and Forecast to 2030 (US$ Million)
7.9 Ophthalmic Aids/Implant
7.9.1 Overview
7.9.2 Ophthalmic Aids/Implant: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8. North America Brain Implants Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 North America Brain Implants Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Chronic Pain
8.3.1 Overview
8.3.2 Chronic Pain: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Parkinson’s disease
8.4.1 Overview
8.4.2 Parkinson’s disease: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Alzheimer’s disease
8.5.1 Overview
8.5.2 Alzheimer’s disease: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Epilepsy
8.6.1 Overview
8.6.2 Epilepsy: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Essential Tremor
8.7.1 Overview
8.7.2 Essential Tremor: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Depression
8.8.1 Overview
8.8.2 Depression: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.9 Dystonia
8.9.1 Overview
8.9.2 Dystonia: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.10 Amyotrophic Lateral Sclerosis
8.10.1 Overview
8.10.2 Amyotrophic Lateral Sclerosis (ALS): North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.11 Neurofibromatosis 2
8.11.1 Overview
8.11.2 Neurofibromatosis 2: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Brain Implants Market – Revenue and Forecast to 2030 – by End-User
9.1 Overview
9.2 North America Brain Implants Market Revenue Share, by End-User, 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Specialized Clinics / Neurological Centers
9.4.1 Overview
9.4.2 Specialized Clinics / Neurological Centers: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Brain Implants Market – Geographical Analysis
10.1 North America North America Brain Implants Market, by Key Country-Revenue (2022)
10.1.1.1 North America North America Brain Implants Market, by Country
10.1.1.2 US
10.1.1.2.1 US: North America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.2 US: North America Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.2.2.1 US: North America Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.2.3 US: North America Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.2.4 US: North America Brain Implants Market, by End-User, 2020-2030 (US$ Million)
10.1.1.3 Canada
10.1.1.3.1 Canada: North America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.2 Canada: North America Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.3.2.1 Canada: North America Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.3.3 Canada: North America Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.3.4 Canada: North America Brain Implants Market, by End-User, 2020-2030 (US$ Million)
10.1.1.4 Mexico
10.1.1.4.1 Mexico : North America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.2 Mexico: North America Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.4.2.1 Mexico: North America Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.4.3 Mexico: North America Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.4.4 Mexico: North America Brain Implants Market, by End-User, 2020-2030 (US$ Million)
11. Brain Implants Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in Brain Implants Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Boston Scientific Corp
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Functional Neuromodulation Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 SWOT Analysis
12.3.5 Key Developments
12.4 Fisher Wallace Laboratories Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Synchron Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 SWOT Analysis
12.5.5 Key Developments
12.6 Blackrock Microsystems Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 SWOT Analysis
12.6.5 Key Developments
12.7 Renishaw Plc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Abbott Laboratories
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Neurospine LLC
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 SWOT Analysis
12.9.5 Key Developments
12.10 BrainGate
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 SWOT Analysis
12.10.5 Key Developments
12.11 NeuroSky Inc
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 SWOT Analysis
12.11.5 Key Developments
12.12 Neuralink Corp
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 SWOT Analysis
12.12.5 Key Developments
12.13 NeuroPace Inc
12.13.1 Key Facts
12.13.2 Business Description
12.13.3 Products and Services
12.13.4 Financial Overview
12.13.5 SWOT Analysis
12.13.6 Key Developments
12.14 ONWARD Medical NV
12.14.1 Key Facts
12.14.2 Business Description
12.14.3 Products and Services
12.14.4 Financial Overview
12.14.5 SWOT Analysis
12.14.6 Key Developments
12.15 Paradromics Inc
12.15.1 Key Facts
12.15.2 Business Description
12.15.3 Products and Services
12.15.4 SWOT Analysis
12.15.5 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Brain Implants Market Segmentation
Table 2. US: North America Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 3. US: North America Brain Implants Market, by Auditory Brainstem Implants- Revenue and Forecast to 2030 (US$ Million)
Table 4. US: North America Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 5. US: North America Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 6. Canada: North America Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 7. Canada: North America Brain Implants Market, by Auditory Brainstem Implants- Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada: North America Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada: North America Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 10. Mexico : North America Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 11. Mexico : North America Brain Implants Market, by Auditory Brainstem Implants- Revenue and Forecast to 2030 (US$ Million)
Table 12. Mexico : North America Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico : North America Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 14. Recent Organic Growth Strategies in Brain Implants Market
Table 15. Recent Inorganic Growth Strategies in the Brain Implants Market
Table 16. Glossary of Terms, North America Brain Implants Market
LIST OF FIGURES
Figure 1. North America Brain Implants Market Segmentation, By Country
Figure 2. North America PEST Analysis
Figure 3. North America Brain Implants Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. North America Brain Implants Market Revenue (US$ Mn), 2022 – 2030
Figure 6. North America Brain Implants Market Revenue Share, by Treatment, 2022 & 2030 (%)
Figure 7. Deep Brain Stimulation: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Spinal Cord Stimulation: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Vagus Nerve Stimulator: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Invasive and Non-Invasive Brain-Computer Interfaces: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Responsive Neurostimulation for Seizures: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Auditory Brainstem Implant: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Retrocochlear Hearing Impairment: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Cochlear Hearing Impairment: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Ophthalmic Aids/Implant: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. North America Brain Implants Market Revenue Share, by Application 2022 & 2030 (%)
Figure 17. Chronic Pain: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Parkinson’s disease: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Alzheimer’s disease: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Epilepsy: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Essential Tremor: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Depression: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Dystonia: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Amyotrophic Lateral Sclerosis (ALS): North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Neurofibromatosis 2: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. North America Brain Implants Market Revenue Share, by End-User, 2022 & 2030 (%)
Figure 27. Hospitals: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Specialized Clinics / Neurological Centers: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. North America: Brain Implants Market, by Key Country – Revenue (2022) (US$ Million)
Figure 30. North America Brain Implants Market, By Key Countries, 2022 and 2030 (%)
Figure 31. US: North America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Canada: North America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 33. Mexico : North America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Growth Strategies in Brain Implants Market
The List of Companies – North America Brain Implants Market
1. Abbott Laboratories
2. Blackrock Microsystems Inc
3. Boston Scientific Corp
4. BrainGate
5. Fisher Wallace Laboratories Inc
6. Functional Neuromodulation Ltd
7. Medtronic Plc
8. Neuralink Corp
9. NeuroPace Inc
10. NeuroSky Inc
11. Neurospine LLC
12. ONWARD Medical NV
13. Paradromics Inc
14. Renishaw Plc
15. Synchron Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.